Press release
Global mRNA Synthesis and Manufacturing Market to grow at a CAGR of 4.32% by 2032, Evaluates DelveInsight
DelveInsight's "mRNA Synthesis and Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key mRNA Synthesis and Manufacturing companies actively working in the market.
To know more about why North America is leading the market growth in the mRNA Synthesis and Manufacturing market, get a snapshot of the report mRNA Synthesis and Manufacturing Market Trends
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
mRNA Synthesis and Manufacturing Overview
mRNA synthesis and manufacturing refer to the process of creating messenger RNA (mRNA) molecules that instruct cells to produce specific proteins for therapeutic or vaccine purposes. This involves in vitro transcription, where a DNA template is used to synthesize mRNA, followed by purification, formulation, and quality control to ensure stability and efficacy. mRNA manufacturing plays a crucial role in developing mRNA-based vaccines, gene therapies, and cancer immunotherapies, offering rapid production capabilities and adaptability for emerging diseases.
DelveInsight Analysis: The global mRNA synthesis and manufacturing market size is projected to expand at a compound annual growth rate (CAGR) of 4.32% between 2025 and 2032.
mRNA Synthesis and Manufacturing Market Insights
Geographically, North America is projected to hold the largest share of the mRNA synthesis and manufacturing market in 2024. The region hosts a strong network of leading biotechnology and pharmaceutical companies, including Moderna and Pfizer, which play a pivotal role in advancing mRNA vaccine development and large-scale production. Its well-established research infrastructure, supportive regulatory environment-such as the FDA's expedited approval processes-and increasing adoption of mRNA therapies for cancer immunotherapy and infectious diseases further drive growth. In addition, rising investments in manufacturing facilities and expanding industry collaborations continue to boost innovation and capacity, reinforcing North America's leadership in the global mRNA market.
To read more about the latest highlights related to mRNA Synthesis and Manufacturing, get a snapshot of the key highlights entailed in the mRNA Synthesis and Manufacturing Market Insights
https://www.delveinsight.com/report-store/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the mRNA Synthesis and Manufacturing Market Report
• In August 2024, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for the updated mRNA COVID-19 vaccine (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.
• In April 2024, TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company and global provider of life science reagents and services, announced the grand opening of its new cGMP mRNA manufacturing facility.
• In September 2023, PackGene Biotech and Kudo Biotechnology partnered to offer customized mRNA manufacturing services.
• In August 2022, New England Biolabs® introduced Faustovirus Capping Enzyme, a novel enzymatic mRNA capping solution for mRNA manufacturing.
• Thus, owing to such developments in the market, rapid growth will be observed in the mRNA Synthesis and Manufacturing market during the forecast period
Key Players in the mRNA Synthesis and Manufacturing Market
Some of the key market players operating in the mRNA Synthesis and Manufacturing market include- Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc., Promega Corporation, Jena Bioscience, GenScript, RiboPro, Takara Bio, Lonza, Sigma-Aldrich, Agilent Technologies, Integrated DNA Technologies, Inc., and others.
Which MedTech key players in the mRNA Synthesis and Manufacturing market are set to emerge as the trendsetter explore @ Key mRNA Synthesis and Manufacturing Companies
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the mRNA Synthesis and Manufacturing Market Landscape
Furthermore, numerous reagents and kits are now developed for specialized applications, such as mRNA capping or tailing, to meet a wide range of research requirements. For example, in November 2021, New England Biolabs (NEB®) launched the HiScribe T7 mRNA Kit, incorporating TriLink Biotechnologies' CleanCap Reagent AG. This innovation enables the efficient synthesis of high-yield mRNA with a Cap 1 structure in a single-step process, making it ideal for research and preclinical studies. The kit's scalable design also supports smooth transitions to large-scale therapeutic mRNA production, including vaccines. Additionally, NEB has introduced GMP-grade kits, enzymes, and reagents to address the rising demand for high-quality RNA synthesis in therapeutic manufacturing.
Collectively, these advancements are expected to strengthen this segment, thereby driving the overall growth of the global mRNA synthesis and manufacturing market.
Scope of the mRNA Synthesis and Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• mRNA Synthesis and Manufacturing Market Segmentation By Product Type: Instruments and Reagents & Kits
• mRNA Synthesis and Manufacturing Market Segmentation By Application: (Research and Manufacturing
• mRNA Synthesis and Manufacturing Market Segmentation By End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and CROs & CDMOs
• mRNA Synthesis and Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key mRNA Synthesis and Manufacturing Companies: Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc., Promega Corporation, Jena Bioscience, GenScript, RiboPro, Takara Bio, Lonza, Sigma-Aldrich, Agilent Technologies, Integrated DNA Technologies, Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the mRNA Synthesis and Manufacturing market will grow by 2032? Click to get a snapshot of the mRNA Synthesis and Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global mRNA Synthesis and Manufacturing Market to grow at a CAGR of 4.32% by 2032, Evaluates DelveInsight here
News-ID: 4243423 • Views: …
More Releases from DelveInsight Business Research
Global Biologics Contract Manufacturing Market to reach USD 47,494.63 million at …
According to DelveInsight's analysis, The increasing incidence of chronic conditions such as cancer, diabetes, and autoimmune diseases is driving the demand for biologic therapies, prompting pharmaceutical companies to outsource large-scale production to contract manufacturers. Additionally, the expanding pipeline of biologics-including monoclonal antibodies, vaccines, and biosimilars-necessitates adaptable manufacturing solutions to address rising market demand efficiently. Moreover, advancements in biotechnology and biomedical techniques, such as recombinant DNA technology and enhanced expression systems,…
Global Pulsed Lavage Systems Devices Market to reach USD 906.40 million at a CAG …
According to DelveInsight's analysis, The pulsed lavage devices market is witnessing substantial growth due to multiple contributing factors. The increasing incidence of orthopedic surgeries, trauma cases, and chronic wounds such as diabetic foot ulcers and pressure ulcers has elevated the need for advanced wound care solutions. Moreover, the heightened emphasis on infection prevention in surgical and wound management practices has made pulsed lavage systems vital for effective cleaning and minimizing…
Global Artificial Pancreas Device System Market to reach USD 1,116.86 million at …
According to DelveInsight's analysis, The global rise in diabetes prevalence is a major factor driving the artificial pancreas device market, as the expanding patient base fuels the need for advanced diabetes management solutions. Growing awareness initiatives and the implementation of screening programs have also enabled earlier diagnosis and improved disease control, boosting the demand for technologies like artificial pancreas systems. Additionally, continuous product innovation and development by leading market players…
Global Prosthetic Heart Valves Market to grow at a CAGR of 11.86% by 2032, Evalu …
According to DelveInsight's analysis, The increasing incidence of valvular heart diseases-including aortic stenosis, mitral regurgitation, and congenital valve defects-driven by an aging population and lifestyle factors such as hypertension and obesity, is substantially boosting the demand for prosthetic heart valves. Enhanced awareness and diagnostic capabilities are leading to earlier detection and timely intervention, further supporting market expansion. Moreover, innovations in valve technologies, such as transcatheter and sutureless prosthetic valves, are…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
